uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A Generic Method for Design of Oligomer-Specific Antibodies
Umeå universitet, Institutionen för medicinsk kemi och biofysik.
Umeå universitet, Institutionen för medicinsk kemi och biofysik.
Umeå universitet, Institutionen för medicinsk kemi och biofysik.
Umeå universitet, Institutionen för medicinsk kemi och biofysik.
Show others and affiliations
2014 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 9, no 3, e90857Article in journal (Refereed) Published
Abstract [en]

Antibodies that preferentially and specifically target pathological oligomeric protein and peptide assemblies, as opposed to their monomeric and amyloid counterparts, provide therapeutic and diagnostic opportunities for protein misfolding diseases. Unfortunately, the molecular properties associated with oligomer-specific antibodies are not well understood, and this limits targeted design and development. We present here a generic method that enables the design and optimisation of oligomer-specific antibodies. The method takes a two-step approach where discrimination between oligomers and fibrils is first accomplished through identification of cryptic epitopes exclusively buried within the structure of the fibrillar form. The second step discriminates between monomers and oligomers based on differences in avidity. We show here that a simple divalent mode of interaction, as within e. g. the IgG isotype, can increase the binding strength of the antibody up to 1500 times compared to its monovalent counterpart. We expose how the ability to bind oligomers is affected by the monovalent affinity and the turnover rate of the binding and, importantly, also how oligomer specificity is only valid within a specific concentration range. We provide an example of the method by creating and characterising a spectrum of different monoclonal antibodies against both the A beta peptide and alpha-synuclein that are associated with Alzheimer's and Parkinson's diseases, respectively. The approach is however generic, does not require identification of oligomer-specific architectures, and is, in essence, applicable to all polypeptides that form oligomeric and fibrillar assemblies.

Place, publisher, year, edition, pages
2014. Vol. 9, no 3, e90857
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:uu:diva-310048DOI: 10.1371/journal.pone.0090857ISI: 000332842400033PubMedID: 24618582OAI: oai:DiVA.org:uu-310048DiVA: diva2:1054789
Funder
Swedish Research CouncilMagnus Bergvall FoundationTorsten Söderbergs stiftelse
Available from: 2016-12-09 Created: 2016-12-09 Last updated: 2016-12-09Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sellin, Mikael E.
In the same journal
PLoS ONE
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 52 hits
ReferencesLink to record
Permanent link

Direct link